findmyKOL
Clinical trialNCT07759245Not, yet, recruitingPhase 2Interventional

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

SponsorEli Lilly and CompanyEnrollment606Pulmonary Disease, Chronic Obstructive
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The main purpose of this study is to assess if different dose levels of Brenipatide are safe and work the way they are intended to work in participants with moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD), when compared with placebo. The study will last approximately one year.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)

    Eli Lilly and Company

    Study Director

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

128 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina
  • Centro Médico Viamonte

    Buenos Aires, Argentina

    Walter Mattarucco
  • Consultorios Médicos, Organización del Buen Ayre S.R.L.

    Buenos Aires, Argentina

    Silvina Riva
  • Fundación Respirar

    Buenos Aires, Argentina

    Pablo Doreski
  • Fundacion Scherbovsky

    Mendoza, Argentina

    Pablo Saez Scherbovsky
  • Instituto Médico Río Cuarto

    Río Cuarto, Argentina

    Carolina Cappelletti
  • Centro de Salud E Investigaciones Médicas

    Santa Rosa, Argentina

    Federico Promencio
Austria
  • Private Practice - Dr. Robert Voves

    Feldbach, Austria

    Robert Voves
  • Klinikum Klagenfurt Am Wörthersee

    Klagenfurt, Austria

    Daniel Doberer
  • Ordination Für Lungenkrankheiten

    Linz, Austria

    Michael Würtz
  • Klinik Floridsdorf

    Vienna, Austria

    Arschang Valipour
Canada
  • Kelowna Health and Memory Centre

    Kelowna, Canada

    Colleen Maytham
  • Diex Recherche Inc. Division Sherbrooke Est

    Sherbrooke, Canada

    Jean-louis Aube
  • Inspiration Research

    Toronto, Canada

    Kenneth Chapman
  • C.I.C. Mauricie Inc.

    Trois-Rivières, Canada

    Pierre-Alexandre Menard
  • Dr. Syed Anees Medicine Professional Corporation

    Windsor, Canada

    Syed Anees
China
  • the First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technolo -T

    Baotou, China

    Gaizhen Ge
  • China-Japan Friendship Hospital

    Beijing, China

    Ting Yang
  • Sichuan Provincial People'S Hospital

    Chengdu, China

    Haiying Yan
  • the First Affiliated Hospital of Guangzhou Medical University

    Guangzhou, China

    Dongxing Zhao
  • Jiangyin People'S Hospital

    Jiangyin, China

    Chengying Liu
  • Jinan Central Hospital

    Jinan, China

    Xin Wang
  • Pingxiang People'S Hospital

    Pingxiang, China

    Xiangbo Shen
  • Shanghai General Hospital

    Shanghai, China

    Min Zhang
  • Shenzhen People'S Hospital

    Shenzhen, China

    lingwei wang
  • Tianjin Medical University General Hospital

    Tianjin, China

    Jie Cao
  • the Second Affiliated Hospital of Xi'An Jiaotong University

    Xi'an, China

    Jie Zhang
  • the First People'S Hospital of Xinxiang

    Xinxiang, China

    Chenlong Cao
Czechia
  • Meditrial S.R.O.

    Jindichv Hradec, Czechia

    Petr Kopecky
  • Private Practice - Dr. Ilona Pavlišová

    Miroslav, Czechia

    MUDr.Ilona Pavlisova
  • Ccr Ostrava S.R.O

    Ostrava, Czechia

    Maksym Semeniuk
  • Ordinace Chorob Plicních

    Prague, Czechia

    Zuzana Kovarikova
Denmark
  • Aalborg Universitetshospital, Syd

    Aalborg, Denmark

    Weinreich Ulla
  • Aarhus Universitetshospital, Skejby

    Aarhus, Denmark

    Andreas Hvass
  • Bispebjerg Hospital

    Copenhagen, Denmark

    Asger Sverrild
  • Esbjerg Sygehus, Syddansk Universitetshospital

    Esbjerg, Denmark

    finn rasmussen
  • Hvidovre Hospital

    Hvidovre, Denmark

    Charlotte Ulrik
  • Roskilde Sygehus

    Roskilde, Denmark

    Christian Meyer
  • Vejle Sygehus

    Vejle, Denmark

    Ole Hilberg
France
  • Chru de Brest

    Brest, France

    Christophe Gut-Gobert
  • Centre Hospitalier de Cholet

    Cholet, France

    JEREMIE POILANE
88 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

BrenipatidePlaceboStandard of Care
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Aug 2026
Primary completion
31 May 2028
Completion
30 Nov 2028
Last update posted
12 Aug 2026
Registered enrollment
606
Registry id
NCT07759245

Cross-registrations

EU-CTR / CTIS (EudraCT)2026-525480-41-00

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.